Legal Statement for the Amarillo Biosciences, Inc. Internet site.
Amarillo Biosciences, Inc. has made and will continue to make great efforts to include accurate and up-to-date information on its World Wide Web site. However, Amarillo Biosciences makes no warranties or representations, express or implied, as to the accuracy or completeness of the information contained or referenced therein. All users agree that all access and use of this site and on any site linked to this site and the content thereof is at their own risk. Neither Amarillo Biosciences Inc. nor any other party involved in creating, producing or delivering this site or on any site linked to this site shall be liable in any manner whatsoever for any direct, incidental, consequential, indirect or punitive damages arising out of your access, use or inability to use this site or any site linked to this site, or any errors or omissions in the content thereof.
The World Wide Website of Amarillo Biosciences and the information contained and referenced therein are for informational purposes only. Any reproduction, retransmission or other use is strictly prohibited. Request for permission to reproduce any information contained on the World Wide Website should be addressed to the Amarillo Biosciences Webmaster.
Except for the historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties, including uncertainties related to product development, uncertainties related to the need for regulatory and other government approvals, dependence on proprietary technology, uncertainty of market acceptance of oral interferon or the Company’s other product candidates and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission. In particular, see “Item 1. Description of Business” and "Item 7A. Qualitative and Quantitative Disclosures About Market Risk" of the Company's Form 10-K for the year ended December 31, 2011.
Last update: December 17, 2012